183 related articles for article (PubMed ID: 32873131)
1. Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.
Deloose K; Bosiers M; Peeters P; Verbist J; Maene L; Beelen R; Keirse K; Hendriks J; Lauwers P; Wauters J; Verschueren M
J Endovasc Ther; 2020 Dec; 27(6):936-945. PubMed ID: 32873131
[TBL] [Abstract][Full Text] [Related]
2. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry.
Tepe G; Zeller T; Moscovic M; Corpataux JM; Christensen JK; Keirse K; Nano G; Schroeder H; Binkert CA; Brodmann M
J Endovasc Ther; 2020 Apr; 27(2):304-315. PubMed ID: 31989855
[No Abstract] [Full Text] [Related]
4. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial.
Scheinert D; Schulte KL; Zeller T; Lammer J; Tepe G
J Endovasc Ther; 2015 Feb; 22(1):14-21. PubMed ID: 25775674
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
[No Abstract] [Full Text] [Related]
6. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
7. Mid-term Efficacy and Safety of Drug-coated Balloon versus Nitinol Bare Metal Stent for Primary Lesions in Femoropopliteal Artery Disease.
Ma H; Zhang X; Li J; Li Q; Li W; Jiao Y; Jiang J; He C; He Z; Li W; Zhang T; Zhang X
Ann Vasc Surg; 2022 Apr; 81():316-323. PubMed ID: 34762999
[TBL] [Abstract][Full Text] [Related]
8. Drug-Coated Balloon for the Treatment of Long-Segment Femoropopliteal Artery Disease: Pooled Analysis from the BIOLUX P-III SPAIN and BIOLUX P-III All-Comers Registry Long Lesion Subgroup.
Angel de Gregorio M; Brodmann M; Ruiz EM; Manteca JC; Salmeron RR; Munoz Ruiz-Canela JJ; Trujillo IG; Tepe G
J Vasc Interv Radiol; 2023 Oct; 34(10):1707-1715.e7. PubMed ID: 37422253
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of the Passeo-18 Lux Drug-Coated Balloon Catheter in Atherosclerotic Femoropopliteal Lesions: The Multicenter BIOLUX P-IV China Study.
Yang J; Yue J; Chen X; Wang H; Jiang W; Huang X; Lu X; Dong H; Li X; Fu W
Ann Vasc Surg; 2023 Jul; 93():275-282. PubMed ID: 36796585
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the Pulsar-18 self-expanding stent with optional drug-coated balloon angioplasty in the treatment of femoropopliteal lesions - the BIOFLEX PEACE All-Comers Registry.
Lichtenberg M; Breuckmann F; Kramer V; Betge S; Sixt S; Hailer B; Nikol S; Arjumand J; Wittenberg G; Teßarek J; Nolte-Ernsting C
Vasa; 2019 Aug; 48(5):425-432. PubMed ID: 30924409
[No Abstract] [Full Text] [Related]
11. Drug-Coated Balloon versus Bare Nitinol Stent in Femoropopliteal Artery: 12 Months Outcome from a Single Center in China.
Zhao H; Ma B; Chen J; Zheng L; Sun CR; Sun MS; Zhang JB; Fan XQ; Liu P; Ye ZD
Ann Vasc Surg; 2021 Jul; 74():367-381. PubMed ID: 33556529
[TBL] [Abstract][Full Text] [Related]
12. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
13. 4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.
Bosiers M; Deloose K; Callaert J; Keirse K; Verbist J; Hendriks J; Lauwers P; D'Archambeau O; Scheinert D; Torsello G; Peeters P
J Endovasc Ther; 2013 Dec; 20(6):746-56. PubMed ID: 24325689
[TBL] [Abstract][Full Text] [Related]
14. Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery.
Deloose K; Lansink W; Brodmann M; Werner M; Keirse K; Gouëffic Y; Verbist J; Maene L; Hendriks J; Brunet J; Ducasse E; Levent K; Sauguet A; Déglise S; Vandael F
Cardiovasc Intervent Radiol; 2022 Dec; 45(12):1855-1859. PubMed ID: 36058996
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry.
Tepe G; Zeller T; Moscovic M; Corpataux JM; Christensen JK; Keirse K; Nano G; Schroeder H; Binkert CA; Brodmann M
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):207-217. PubMed ID: 33083853
[TBL] [Abstract][Full Text] [Related]
16. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
Gouëffic Y; Torsello G; Zeller T; Esposito G; Vermassen F; Hausegger KA; Tepe G; Thieme M; Gschwandtner M; Kahlberg A; Schindewolf M; Sapoval M; Diaz-Cartelle J; Stavroulakis K;
Circulation; 2022 Nov; 146(21):1564-1576. PubMed ID: 36254728
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
Zhou Y; Wang J; He H; Li Q; Li M; Li X; Shu C
Int J Cardiol; 2021 Nov; 343():122-130. PubMed ID: 34461162
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial.
Teichgräber U; Ingwersen M; Platzer S; Lehmann T; Zeller T; Aschenbach R; Scheinert D
Trials; 2021 Sep; 22(1):665. PubMed ID: 34583746
[TBL] [Abstract][Full Text] [Related]
20. BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries.
Tepe G; Wang J; Corpataux JM; Pua U; Binkert CA; Moscovic M; Ghotbi R; Keirse K; Robertson D; Brodmann M
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):10-18. PubMed ID: 32964317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
